588 Immunoengineering

Thursday, November 19, 2020: 8:00 AM - 9:00 AM
Food, Pharmaceutical & Bioengineering Division (15) (PreRecorded+)

Description:
This session highlights applying cellular engineering concepts to aid in understanding immunology and developing immunotherapies.

Sponsor:
Engineering Fundamentals in Life Science
Co-chairs:
Roger Harrison Email: rharrison@ou.edu
Laurel Hind Email: Laurel.Hind@colorado.edu


(588a) A Low Affinity Humanized CD-19 Targeted Chimeric Antigen Receptor Efficiently Controls B-Cell Malignancy
Lawrence A. Stern, Vibuthi Vyas, Laura Lim, Christian Huynh, Wen-Chung Chang, Brenda Aguilar, Zhiqiang Wang, John C. Williams, Stephen J. Forman, Xiuli Wang and Christine E. Brown


(588b) Mac-1 Expression Controls If Immune Cells Can Utilize Upstream Migration
Alexander Buffone Jr. and Daniel A. Hammer


(588c) Metabolite-Based Modulation of Dendritic Cells for Developing Effective Immunotherapy
Sahil Inamdar, Joslyn L. Mangal, Deepanjan Ghosh, Subhadeep Dutta, Yi Yang, Xiaojin Shi, Haiwei Gu, Matthew D. Green, Marion Curtis, Kaushal Rege and Abhinav P. Acharya


(588d) Elucidating the Role of Decellularized Porcine Skeletal Muscle ECM-Silk Composite Systems on Human THP-1-Derived Macrophage Polarization
Julie F. Jameson, Caroline L. Hamric and Whitney L. Stoppel


(588e) Characterization and Modeling of Regulatory T Cell Enrichment through Immunophenotypic Modulation
David McBride, Matthew Kerr, Yvonne Yee, Shinya Wai and Nisarg Shah


(588f) Identification and Characterization of a First Responder Cells: A Dendritic Cell Subtype That Coordinates Adaptive Immune Responses
Peter Deak, Bradley Studnitzer and Aaron Esser-Kahn


(588g) Harnessing Biomaterials to Study and Control Immune Function (INVITED SPEAKER)
Christopher Jewell
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>